Invention Grant
![Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis C](/docs/US/2018-06-05/US09987277B2/abs.jpg.600x600.jpg)
- Patent Title: Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis C
-
Application No.: US12443190Application Date: 2007-10-04
-
Publication No.: US09987277B2Publication Date: 2018-06-05
- Inventor: Pierre Jean-Marie Bernard Raboisson , Oliver Lenz , Tse-I Lin , Kenneth Simmen
- Applicant: Pierre Jean-Marie Bernard Raboisson , Oliver Lenz , Tse-I Lin , Kenneth Simmen
- Applicant Address: IE Little Island, Co. Cork
- Assignee: Janssen Sciences Ireland UC
- Current Assignee: Janssen Sciences Ireland UC
- Current Assignee Address: IE Little Island, Co. Cork
- Agency: Baker & Hostetler LLP
- Priority: EP06121756 20061004
- International Application: PCT/EP2007/060539 WO 20071004
- International Announcement: WO2008/040778 WO 20080410
- Main IPC: A61K31/21
- IPC: A61K31/21 ; A61K31/506 ; A61K31/535
![Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis C](/abs-image/US/2018/06/05/US09987277B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to the use of carboxamide 4-[(4-pyridyl)amino]-pyrimidines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections.
Public/Granted literature
- US20090247523A1 CARBOXAMIDE 4-[(4-PYRIDYL)AMINO]PYRIMIDINES USEFUL AS HCV INHIBITORS Public/Granted day:2009-10-01
Information query
